SNY
Sanofi (SNY) Q1 2026 Earnings
SNY·Reported April 23, 2026·Before market open
Sanofi reported Q1 2026 revenue of $12.9B (+11.3% YoY), beat analyst consensus of $12.7B by $241.2M. Diluted EPS came in at $1.10 (+17.0% YoY), beat the $1.06 consensus by $0.04.
Revenue
$12.9Bbeat by $241.2M
Consensus: $12.7BDiluted EPS
$1.10beat by $0.04
Consensus: $1.06
SEC Filings
Earnings release8-K not filed yet
Quarterly report10-Q / 10-K not filed yet
Filings will appear here once submitted to SEC EDGAR.
Q1 2026 Earnings FAQ
Common questions about Sanofi's Q1 2026 earnings report.
Sanofi (SNY) reported Q1 2026 earnings on April 23, 2026 before market open.
Sanofi reported revenue of $12.9B and diluted EPS of $1.10 for Q1 2026.
Revenue beat the consensus estimate of $12.7B by $241.2M. EPS beat the consensus estimate of $1.06 by $0.04.
Compared to the same quarter a year prior, revenue grew 11.3% from $11.6B a year earlier and diluted EPS grew 17.0% from $0.94.